Literature DB >> 17826653

Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.

Rauf Taner Divrik1, Aşkin Eroglu, Ali Sahin, Ferruh Zorlu, Haluk Ozen.   

Abstract

PURPOSE: To determine the importance of increasing the number of biopsy cores to decrease the discrepancy of Gleason scores of needle biopsy and radical prostatectomy specimens.
MATERIALS AND METHODS: Between May 1998 and July 2005, 392 patients with clinically localized prostate cancer diagnosed by 18-gauge transrectal needle biopsy underwent radical prostatectomy. We categorized the cohort into 2 groups according to the number of the cores. Group 1 consisted of 206 patients diagnosed by extended biopsies (> or =10 cores, range 10-14, median 11). The remaining 186 patients who were diagnosed by sextant biopsies were categorized as being in group 2. Preoperative clinical variables, including patient age, digital rectal examination findings, serum prostate-specific antigen, and the number of cores positive for cancer the parameters, were assessed in both groups. The concordance of Gleason scores in both groups were analyzed by both individual Gleason scores and clinical subgroups of Gleason scores: 2-4 (well differentiated), 5-6 (moderately differentiated), 7 (intermediate), and 8-10 (poorly differentiated).
RESULTS: Needle biopsies revealed moderately differentiated tumors (Gleason 5-6) for the 2 groups (55.3% and 60.2%). Gleason scores of the needle biopsies were identical to that of the prostatectomy specimen in 116 (56.31%) and 76 cases (40.86%) for each group (kappa: 0.432 and 0.216 for each group, respectively). Gleason score of the needle biopsy differed by 1 grade in 56 (27.18%) and 84 cases (45.16%), and by > or =2 units in 34 (16.50%) and 26 cases (15.05%) for each group, respectively. Of the specimens, 34% were undergraded, and 10% were overgraded in group 1. These rates were 38% and 22% in group 2, respectively. A total of 70% in group 1 and 56% in group 2 remained in the same categorical group, 28% and 32% of the specimens were undergraded, and 4% and 12% were overgraded in groups 1 and 2, respectively. In group 1, the number of patients with Gleason scores of 2-4, 5-6, 7, and 8 were 9.7%, 55.3%, 21.4%, 13.6%, and 1.9%, 47.6%, 32%, 18.4%, graded by needle biopsies and radical prostatectomy specimens, respectively. However, in the sextant group, the change was the number of patients with Gleason scores of 2-4, 5-6, 7, and 8-10 was 5.4% 60.2%, 24.7%, and 9.7%, detected by needle biopsies, respectively. Radical prostatectomy specimens revealed the same Gleason categories in 4.3%, 41.9%, 38.7%, and 15.1%, respectively. There was no correlation between categorized prostate-specific antigen levels and concordance of the Gleason grade. Age and digital rectal examination results did not affect Gleason correlation.
CONCLUSIONS: We have shown that an extended biopsy scheme beyond its superior diagnostic capability also improves the concordance of Gleason scores of needle biopsies and radical prostatectomy specimens.

Entities:  

Mesh:

Year:  2007        PMID: 17826653     DOI: 10.1016/j.urolonc.2006.08.028

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  23 in total

Review 1.  When prostate cancer remains undetectable: The dilemma.

Authors:  Mahmoud Othman Mustafa; Louis Pisters
Journal:  Turk J Urol       Date:  2015-03

Review 2.  Current perspectives on Gleason grading of prostate cancer.

Authors:  Kenneth A Iczkowski; M Scott Lucia
Journal:  Curr Urol Rep       Date:  2011-06       Impact factor: 3.092

3.  The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancer.

Authors:  Al B Barqawi; Ruslan Turcanu; Eduard J Gamito; Scott M Lucia; Colin I O'Donnell; E David Crawford; David D La Rosa; Francisco G La Rosa
Journal:  Int J Clin Exp Pathol       Date:  2011-06-12

4.  Pathological Correlation between Number of Biopsies and Radical Surgery: Does It Make a Difference to Final Pathology?

Authors:  Tahir Qayyum; Jennifer M Willder; Paul G Horgan; Joanne Edwards; Mark A Underwood
Journal:  Curr Urol       Date:  2013-07-28

5.  T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.

Authors:  Gabriel Nketiah; Mattijs Elschot; Eugene Kim; Jose R Teruel; Tom W Scheenen; Tone F Bathen; Kirsten M Selnæs
Journal:  Eur Radiol       Date:  2016-12-14       Impact factor: 5.315

Review 6.  Correlation between Gleason Scores in Needle Biopsy and Corresponding Radical Prostatectomy Specimens: A Twelve-Year Review.

Authors:  Maliheh Khoddami; Yassaman Khademi; Maryam Kazemi Aghdam; Haleh Soltanghoraee
Journal:  Iran J Pathol       Date:  2016

7.  In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? A pilot test-retest reliability study.

Authors:  Kareem K Elfatairy; Christopher P Filson; Martin G Sanda; Adeboye O Osunkoya; Rachel L Geller; Sherif G Nour
Journal:  Br J Radiol       Date:  2018-02-13       Impact factor: 3.039

8.  In-Bore MRI-guided Prostate Biopsies in Patients with Prior Positive Transrectal US-guided Biopsy Results: Pathologic Outcomes and Predictors of Missed Cancers.

Authors:  Kareem K Elfatairy; Christopher P Filson; Martin G Sanda; Adeboye O Osunkoya; Sherif G Nour
Journal:  Radiol Imaging Cancer       Date:  2020-09-25

Review 9.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

10.  Clinical and pathological variables that predict changes in tumour grade after radical prostatectomy in patients with prostate cancer.

Authors:  Stavros Sfoungaristos; Petros Perimenis
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.